As reported by The Daily Telegraph, the world leading pharmaceutical company AstraZeneca has set up a dedicated to team which will push to develop scientific collaborations with governments, charities, universities and businesses.
The team, named the Science and Technology Integration office, has already been making headway with this – last month they secured a deal with the Medical Research Council to share potential drugs for free with academics. As part of the partnership, these academics will be exploring how 22 of AstraZeneca’s clinical compounds could be used to treat different diseases.
The announcement of AstraZeneca’s increasing commitment to developing partnerships is reflective of the wider pharmaceutical industry – with many of the big pharmaceutical companies striving to create partnerships which will help them discover new medicines in a cost effective way. It’s also a great way to face increasing competition from cheaper generics companies.